| MP3 players and hearing loss: adolescents’ perceptions of loud music and hearing conservation I Vogel, J Brug, EJ Hosli, CPB Van Der Ploeg, H Raat The Journal of pediatrics 152 (3), 400-404. e1, 2008 | 209 | 2008 |
| Helmet therapy in infants with positional skull deformation: randomised controlled trial RM van Wijk, LA van Vlimmeren, CGM Groothuis-Oudshoorn, ... Bmj 348, 2014 | 202 | 2014 |
| Adolescents and MP3 players: too many risks, too few precautions I Vogel, H Verschuure, CPB van der Ploeg, J Brug, H Raat Pediatrics 123 (6), e953-e958, 2009 | 172 | 2009 |
| Young people’s exposure to loud music: a summary of the literature I Vogel, J Brug, CPB Van der Ploeg, H Raat American journal of preventive medicine 33 (2), 124-133, 2007 | 122 | 2007 |
| Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population EL Korenromp, C Van Vliet, H Grosskurth, A Gavyole, CPB Van der Ploeg, ... Aids 14 (5), 573-593, 2000 | 120 | 2000 |
| Estimating adolescent risk for hearing loss based on data from a large school-based survey I Vogel, H Verschuure, CPB van der Ploeg, J Brug, H Raat American Journal of Public Health 100 (6), 1095-100, 2010 | 113 | 2010 |
| The LYMFASIM simulation program for modeling lymphatic filariasis and its control AP Plaisier, S Subramanian, PK Das, W Souza, T Lapa, AF Furtado, ... Methods of information in medicine 37 (01), 97-108, 1998 | 104 | 1998 |
| Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands M De Haas, FF Thurik, CPB Van Der Ploeg, B Veldhuisen, H Hirschberg, ... bmj 355, 2016 | 103 | 2016 |
| STDSIM: a microsimulation model for decision support in STD control CPB Van der Ploeg, C Van Vliet, SJ De Vlas, JO Ndinya-Achola, ... Interfaces 28 (3), 84-100, 1998 | 102 | 1998 |
| Adolescents risky MP3-player listening and its psychosocial correlates I Vogel, J Brug, CPB Van der Ploeg, H Raat Health education research 26 (2), 254-264, 2011 | 90 | 2011 |
| Ivermectin for the chemotherapy of bancroftian filariasis: a meta‐analysis of the effect of single treatment W Cao, CPB Van der Ploeg, AP Plaisier, IJS van der Sluijs, JDF Habbema Tropical Medicine & International Health 2 (4), 393-403, 1997 | 85 | 1997 |
| Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study AMM Vernooij-van Langen, JG Loeber, B Elvers, RH Triepels, JJP Gille, ... Thorax 67 (4), 289-295, 2012 | 83 | 2012 |
| Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective EO de Coul, S Hahne, Y van Weert, P Oomen, C Smit, K van der Ploeg, ... BMC infectious diseases 11 (1), 185, 2011 | 76 | 2011 |
| Risk indicators for hearing loss in infants treated in different neonatal intensive care units P Van Dommelen, AD Mohangoo, PH Verkerk, CPB Van Der Ploeg, ... Acta Paediatrica 99 (3), 344-349, 2010 | 70 | 2010 |
| Strategies for the prevention of MP3-induced hearing loss among adolescents: Expert opinions from a Delphi study I Vogel, J Brug, CPB van der Ploeg, H Raat Pediatrics 123 (5), 1257-1262, 2009 | 68 | 2009 |
| Burden of sickness absence due to chronic disease in the Dutch workforce from 2007 to 2011 EMM de Vroome, K Uegaki, CPB van der Ploeg, DB Treutlein, ... Journal of occupational rehabilitation 25 (4), 675-684, 2015 | 67 | 2015 |
| Risk factors for human cysticercosis morbidity: a population-based case-control study W Cao, CPB Van Der Ploeg, J Xu, C Gao, L Ge, JDF Habbema Epidemiology & Infection 119 (2), 231-235, 1997 | 53 | 1997 |
| Discotheques and the risk of hearing loss among youth: risky listening behavior and its psychosocial correlates I Vogel, J Brug, CPB Van der Ploeg, H Raat Health education research 25 (5), 737-747, 2010 | 46 | 2010 |
| Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data CPB Van Der Ploeg, ME Van den Akker-van Marle, ... Journal of Cystic Fibrosis 14 (2), 194-202, 2015 | 45 | 2015 |
| A nation‐wide fetal RHD screening programme for targeted antenatal and postnatal anti‐D M De Haas, CPB Van der Ploeg, PG Scheffer, DA Verlinden, ... ISBT Science Series 7 (1), 164-167, 2012 | 45 | 2012 |
PH VerkerkTNO LeidenVerified email at tno.nl
